Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report
13 medications in this reportExample report
Oncology
Chemotherapies · Estrogen Modulators
- Consider alternative 1
- Use with caution 1
- Use as directed 11
The genes behind these labels
- CYP2D6Poor metabolizer*4/*4 · Changes the guidance for 2 of 2
- UGT1A1Intermediate metabolizer*1/*28+*60+*80 · Read for 5, changes none
- DPYDNormal metabolizerReference/Reference · Read for 2, changes none
- NUDT15Normal metabolizer*1/*1 · Read for 2, changes none
- TPMTNormal metabolizer*1/*1 · Read for 2, changes none
- CYP2C19Intermediate metabolizer*1/*2 · Read for 1, changes none
- CYP2C9Intermediate metabolizer*1/*2 · Read for 1, changes none
The oncology by label
Open any medication for the results behind its label and the guidelines in full.
Consider alternative 1 medication
Use with caution 1 medication
Use as directed 11 medications
- BelinostatBeleodaq Chemotherapies Use as directed Your body may process this drug a little more slowly. The FDA has no special advice for this, so the usual dose is used.UGT1A1Intermediate metabolizer
- BelzutifanWelireg Chemotherapies Use as directed Your CYP2C19 result means somewhat lower CYP2C19 activity than usual, but the FDA gives no genetic dosing change for belzutifan at this result.CYP2C19Intermediate metabolizer
- CapecitabineXeloda, Xitabin, Kapetral Chemotherapies Use as directed Your body processes capecitabine normally. You have a typical risk of side effects, and the standard dose is expected to be appropriate.DPYDNormal metabolizer
- ErdafitinibBalversa Chemotherapies Use as directed Your CYP2C9 result means somewhat lower CYP2C9 activity than usual, but the FDA gives no genetic dosing change for erdafitinib at this result.CYP2C9Intermediate metabolizer
- FluorouracilAdrucil, Carac Chemotherapies Use as directed Your body breaks down this drug normally. Your risk of side effects is typical, and the usual dose is used.DPYDNormal metabolizer
- IrinotecanCamptosar, Onivyde Chemotherapies Use as directed Your body breaks down irinotecan slightly slower than normal. The standard dose should work as expected.UGT1A1Intermediate metabolizer
- MercaptopurinePurinethol Chemotherapies Use as directed Both genes that affect this drug look normal, so a standard starting dose is expected.TPMTNormal metabolizerNUDT15Normal metabolizer
- NilotinibTasigna Chemotherapies Use as directed Your UGT1A1 result means somewhat lower UGT1A1 activity than usual, but the FDA gives no genetic dosing change for nilotinib at this result.UGT1A1Intermediate metabolizer
- PazopanibVotrient Chemotherapies Use as directed Your UGT1A1 gene works a bit less than average. The FDA gives no dose change for your result, so the usual dose is used.UGT1A1Intermediate metabolizer
- Sacituzumab Govitecan-HziyTrodelvy Chemotherapies Use as directed Your body processes this drug a bit slower than average. The FDA gives no dose change for your result, so the usual dose is used.UGT1A1Intermediate metabolizer
- ThioguanineLanvis, Tabloid Chemotherapies Use as directed Both genes that affect this drug look normal, so a standard starting dose is expected.TPMTNormal metabolizerNUDT15Normal metabolizer
Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.